NeuroOne Medical Technologies Corporation NMTC
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -2.30M | -2.09M | -1.44M | -1.62M | -1.50M |
| Total Depreciation and Amortization | 47.00K | 60.00K | 65.50K | 64.30K | 66.60K |
| Total Amortization of Deferred Charges | -- | -- | -- | -192.60K | 0.00 |
| Total Other Non-Cash Items | -21.90K | 379.90K | 165.50K | 896.90K | 41.90K |
| Change in Net Operating Assets | 1.20M | 317.00K | -1.91M | -675.00K | -71.10K |
| Cash from Operations | -1.08M | -1.33M | -3.12M | -1.53M | -1.46M |
| Capital Expenditure | -19.70K | -38.50K | -40.80K | -10.60K | -43.50K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -19.70K | -38.50K | -40.80K | -10.60K | -43.50K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 359.00K | 670.40K | 174.40K | 0.00 | 9.20M |
| Repurchase of Common Stock | -3.20K | -60.80K | -3.60K | -2.80K | -3.50K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -10.80K | 0.00 | -22.90K | 69.70K | -970.00K |
| Cash from Financing | 345.00K | 609.60K | 147.80K | 67.00K | 8.23M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -756.40K | -757.60K | -3.01M | -1.47M | 6.72M |